Skip to main content
Start of content

INST Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication
MINUTES OF PROCEEDINGS
 
Meeting No. 2
 
Tuesday, February 24, 2004
 

The Standing Committee on Industry, Science and Technology met in a televised session at 11:03 a.m. this day, in Room 237-C Centre Block, the Chair, Brent St. Denis, presiding.

 

Members of the Committee present: Gérard Binet, Hon. David Collenette, Paul Crête, Hon. Joe Fontana, Cheryl Gallant, Hon. Gurbax Malhi, Brian Masse, Grant McNally, James Rajotte, Andy Savoy and Brent St. Denis.

 

Acting Members present: Gilbert Barrette for Marlene Jennings, Claude Duplain for Hon. Lyle Vanclief, Réal Ménard for Jocelyne Girard-Bujold and Diane St-Jacques for Hon. Herb Dhaliwal.

 

In attendance: Library of Parliament: Dan Shaw, Analyst; Lalita Acharya, Analyst.

 

Appearing: Hon. Pierre Pettigrew, Minister of Health; Hon. Lucienne Robillard, Minister of Industry.

 

Witnesses: Department of Industry: Rob Sutherland-Brown, Senior Counsel, Legal Services, Justice Canada; Marie-Josée Thivierge, Director General, Marketplace Framework Policy Branch. Department of Health: David K. Lee, Director, Office of Patented Medicines and Liaison, Therapeutic Products Directorate, Health Products and Food Branch. Canadian International Development Agency: David Maloney, Vice-President, Policy Branch; Sandra Black, Director, Social Development Policies. Department of Foreign Affairs: Marie Gervais-Vidricaire, Director General, Global Issues Bureau. Department of International Trade: Suzanne Vinet, Director General, Trade Policy, Services, Investment and Intellectual Property Bureau.

 
Pursuant to the Order of Reference of Thursday, February 12, 2004, the Committee commenced consideration of Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act.
 

The Chair called Clause 1.

 

The Ministers made opening statements and, with the other witnesses, answered questions.

 

At 12:03 p.m., the sitting was suspended.

At 12:05 p.m., the sitting resumed.

 

The witnesses answered questions.

 

At 1:03 p.m., the sitting was suspended.

 

At 1:05 p.m., the Committee resumed sitting in camera.

 
The Committee proceeded to the consideration of matters related to Committee business.
 

It was agreed, — That the proposed schedule of witnesses for Bill C-9, An Act to amend the Patent Act and the Food and Drug Act, be adopted.

 

It was agreed, — That additional meetings on Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act be scheduled, if necessary.

 

It was agreed, — That the Committee endeavour to commence clause-by-clause consideration of Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act on Thursday, March 11, 2004.

 

The Chair presented the First Report from the Subcommittee on Agenda and Procedure which reads as follows:

The Sub-Committee on Agenda and Procedure of the Standing Committee on Industry, Science and Technology has the honour to present its FIRST REPORT.

Your Sub-Committee met on Thursday, February 19, 2004, and agreed to make the following recommendations:

1. That in relation to the Study of Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act, an operational budget of $12, 200 be adopted and submitted to the Standing Committee.

2. That a motion adopted on February 16, 2004 by the Standing Committee be amended as follows: "That the Chair be authorized to hold meetings to receive and publish evidence when a quorum is not present provided that at least four(4) members are present including a member of the opposition".

3. That when the Chair is unable to act in that capacity at or during a meeting of the Committee, the Chair shall designate a member of the Committee to act as Chair at or during the said meeting and such and acting Chair shall be vested with all the powers of the Chairman at or during the said meeting.

4. That meetings on Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act, be held on Tuesdays, Wednesdays and Thursdays, and that they be televised, if possible.

5. That the analysts prepare a list of possible groups of witnesses for the study of Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act.

 

It was agreed, — That the report be amended by increasing the operational budget of $12,200 to $30,200.

 

It was agreed, — That the report of the Subcommittee, as amended, be concurred in.

 

It was agreed, — That a meeting on the Supplementary Estimates (B) 2003-2004 be scheduled for Wednesday, February 25, 2004.

 

It was agreed, — That the Minister of Industry be invited to appear in relation to the Main Estimates 2004-2005 on Thursday, March 25, 2004.

 

It was agreed, — That the analysts seek advice from the Law Clerk on the issue of draft regulations.

 

At 1:44 p.m., the Committee adjourned to the call of the Chair.

 



Louise M. Thibault
Clerk of the Committee

 
 
2004/03/01 2:03 p.m.